Arrowstreet Capital’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-159,002
| Closed | -$779K | – | 1450 |
|
|
2022
Q3 | $779K | Buy |
159,002
+145,983
| +1,121% | +$715K | ﹤0.01% | 1030 |
|
|
2022
Q2 | $54K | Buy |
+13,019
| New | +$54K | ﹤0.01% | 1200 |
|
|
2021
Q1 | – | Sell |
-98,603
| Closed | -$1.54M | – | 2498 |
|
|
2020
Q4 | $1.54M | Sell |
98,603
-71,297
| -42% | -$1.11M | ﹤0.01% | 1691 |
|
|
2020
Q3 | $1.61M | Buy |
169,900
+99,331
| +141% | +$939K | ﹤0.01% | 1653 |
|
|
2020
Q2 | $632K | Sell |
70,569
-1,231
| -2% | -$11K | ﹤0.01% | 1909 |
|
|
2020
Q1 | $457K | Buy |
+71,800
| New | +$457K | ﹤0.01% | 1549 |
|
|
2018
Q2 | – | Sell |
-234,064
| Closed | -$4.45M | – | 1280 |
|
|
2018
Q1 | $4.45M | Buy |
+234,064
| New | +$4.45M | 0.01% | 596 |
|
|
2016
Q4 | – | Sell |
-90,522
| Closed | -$419K | – | 2393 |
|
|
2016
Q3 | $419K | Buy |
+90,522
| New | +$419K | ﹤0.01% | 1287 |
|
|
2014
Q3 | – | Sell |
-18,329
| Closed | -$280K | – | 1105 |
|
|
2014
Q2 | $280K | Buy |
+18,329
| New | +$280K | ﹤0.01% | 886 |
|
|
2013
Q4 | – | Sell |
-15,239
| Closed | -$160K | – | 1275 |
|
|
2013
Q3 | $160K | Buy |
+15,239
| New | +$160K | ﹤0.01% | 915 |
|